Moderna, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Moderna, Inc. stock issued during period, value, new issues for the quarter ending 2020-12-31 was $0.00.
- Moderna, Inc. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $0.00.
- Moderna, Inc. stock issued during period, value, new issues for the quarter ending 2020-06-30 was $1.30B.
- Moderna, Inc. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $550.00M.
- Moderna, Inc. stock issued during period, value, new issues for fiscal 2020 was $1.85B.
- Moderna, Inc. stock issued during period, value, new issues for fiscal 2018 was $563.03M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $1.85B 10-K · filed 2023-02-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | |
| 2020-06-30 | $1.30B 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $550.00M 10-Q · filed 2021-05-06 | |
| 2018-12-31 | $562.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $563.03M 10-K · filed 2021-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | |
| 2018-03-31 | $152.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |